We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Directory of current ICH Guidelines which have been implemented by the Medicines and Healthcare products Regulatory Agency.
How to comply with the exemption from the Veterinary Medicines Regulations that allow certain animal medicines to be sold without an authorisation.
Guidance for the pharmaceutical industry on Marketing Authorisations for veterinary medicines.
Get help to classify organic chemicals that contain certain permitted additives or can be dissolved in water, for import and export.
The MHRA will introduce a patient alert card to increase awareness among men taking finasteride about potential psychiatric and sexual side effects
Further measures to be introduced to ensure patients who are prescribed montelukast for the treatment of asthma are informed of the risk of neuropsychiatric reactions
Guidance for people who have been diagnosed with a mpox infection and who have been advised to self-isolate at home.
These reports explain our assessment of the scientific evidence used to lead to regulatory decisions on the safety of medicines or medicines classes.
Advice to give pregnant women on infections that can be transmitted via contact with animals that are or have recently given birth.
Project Orbis is a programme to review and approve promising cancer drugs helping patients access treatments faster.
How the MHRA makes decisions on when a product is a medical device (borderline products), and which risk class should apply to a medical device.
Covering thalidomide, lenalidomide, and pomalidomide: temporary guidance for pregnancy prevention arrangements for patients taking them during COVID-19
Apply for a promising innovative medicine (PIM) designation or scientific opinion for your medicine from MHRA.
How to comply with the requirements on promoting medicines to the public and to prescribers and suppliers of medicines.
Find out how the Prevent programme supports people who are at risk of becoming involved with terrorism through radicalisation.
The CMA has accepted commitments offered by Google that address the CMA’s competition concerns resulting from investigating Google’s proposals to remove third-party cookies and other functionalities from its Chrome browser.
Use a separate statement of objection form for each Japanese GI product name you object to.
Resources to help local commissioners achieve value for money by estimating the return on investment (ROI) and cost-effectiveness of public health programmes.
Urgent safety updates arising from pharmacovigilance data, including reported adverse events, for veterinary medicines authorised in the UK.
Guidance for the pharmaceutical industry on how to apply for an authorisation to place a veterinary medicine on the UK market or part of, or to expire one.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.